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Chromatography of the soluble porcine lymphocyte phospholipase C on cellulose phosphate r solves the 
activity into two species. An HPLC method is described for separating the enzyme products, Ins 1,2>P 
and Ins IP. Use of these methods reveals that the two iso-enzymes liberate, with a high degree of reproduci- 
bility, characteristic ratios of the two products. This suggests hat the amount of each product produced 
is an inherent property of the enzyme mechanism. 
Phospholipase C Phosphoinositide Inositolphosphate Lymphocyte tranformation 
1. INTRODUCTION 
Stimulation of cell surface receptors by growth 
factors and hormones has, in many cases, been 
shown to involve an enhanced hydrolysis of the 
phosphoinositides by the action of a 
phosphoinositide-specific phosphodiesterase (EC 
3.1.4.10) or phospholipase C [l-3]. There is 
therefore considerable interest in purifying and 
studying the mechanism of action of enzymes of 
this type. Purification studies of this enzyme have 
been confined to the soluble phospholipase C 
which predominates in all tissues studied to date 
[4-61, the activity of which has frequently been 
shown to derive from multiple forms of the en- 
zyme [5-81. There have been recent reports of a 
phospholipase C activity resident within purified 
Abbreviations: PtdIns, phosphatidylinositol; PtdIns 4P, 
phosphatidylinositol 4-phosphate; PtdIns 4SP2, 
phosphatidylinositol 4,5-bisphosphate; GroPIns, glyc- 
erophosphoinositol; Ins lP, inositol l-phosphate; Ins 
2P, inositol2-phosphate; Ins 1,4,5Ps, inositol 1,4,5-tris- 
phosphate; Ins 1,2>P, inositol 1,2-cyclic phosphate; 
Ins (1,2>P)4,5P3, inositol 1,tcyclic 4,5_trisphosphate; 
PMSF, phenylmethylsulphonyl fluoride; DTE, dithio- 
erythritol 
plasma membranes, closely associated with both 
the receptor and GTP-binding proteins [9-l 11. It 
is not yet clear whether the species observed in 
these cases may also exist in a soluble form which 
associates with the membrane upon cell activation. 
In all cases, where investigated, phospholipase C 
action on PtdIns results in the production of both 
Ins 1P and the acid-labile Ins 1,2>P [4,5,12]. Re- 
cent studies with a purified phospholipase C 
isolated from sheep seminal vesicles have shown 
that hydrolysis of PtdIns 4,5P2 or PtdIns 4P also 
yields cyclic inositol polyphosphates in addition to 
the non-cyclic derivatives [13]. Production of 
Ins( 1,2>p)4,5P3 has not yet been demonstrated to 
occur in vivo although this compound has been 
shown to have biological activity in both mobiliz- 
ing intracellular Ca2+ in platelets and inducing 
changes in conductance in Limulus photoreceptor 
cells [14]. In the latter effect, the cyclic form is 
more potent than the non-cyclic form. Recently, 
Ins 1,2>P has been found in vivo upon stimulation 
of pancreatic tissue [15] and although no 
physiological role for this product has been iden- 
tified, it indicates that the cyclic forms of inositol 
polyphosphates may also be produced in vivo. 
We have recently identified in the soluble frac- 
tion of porcine lymphocytes a number of species of 
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phospholipase C which may be resolved by gel- 
filtration chromatography [16]. We report here 
that further purification by cellulose phosphate 
chromatography resolves the major peak of activi- 
ty eluting from such a column into two further 
species, each of which produces very characteristic 
and quite distinct proportions of Ins 1,2>P and Ins 
1P. 
tion, 2.5 ml chloroform/methanol/cone. HCl 
(50:50:0.3, by vol.), the phases then being 
separated by the addition of 0.75 ml of 1 mM 
EDTA in 0.1 M HCl. The upper aqueous phase 
was removed, neutralized with NaOH and 100~1 
of 50 mM mannitol added before it was freeze- 
dried. The sample was made up in 1 ml water (acid 
extraction) or 1 ml of 1 mM EDTA (neutral ex- 
traction) and analysed by HPLC. 
2. MATERIALS AND METHODS 2.3. HPLC standards 
Chromatography media Sephacryl S-200 and 
cellulose phosphate were supplied by Pharmacia 
and Bio-Rad Laboratories, respectively. All 
radiochemicals were obtained from Amersham In- 
ternational and non-radioactive PtdIns from Lipid 
Products. Ins 2P and Folch fraction I were pur- 
chased from Sigma. 
[2-3H]GroPIns was prepared by alkaline 
hydrolysis 1171 of [2-3H]PtdIns extracted [181 from 
[2-3H]inositol-labelled isaggregated liver cells and 
purified by DE-52 column chromatography using 
1 g Folch fraction I as a carrier [19]. 
2.1. Purification of phospholipase C 
Phospholipase C was isolated from porcine 
mesenteric lymph node lymphocytes as described 
in [16]. The initial step in the purification pro- 
cedure was that of gel filtration on a Sephacryl 
S-200 column (90 x 2.5 cm) eluting with 50 mM 
Tris-HCl (pH 7.2), 1 mM EGTA, 100 ,uM PMSF, 
200 ,uM DTE, which gave a similar profile to that 
resulting from chromatography on Sephadex 
G-200 [16]. The major peak, peak II, was pooled, 
concentrated and equilibrated with 50 mM citric 
acid/trisodium citrate (pH 5.8), 1 mM EGTA, 
100 pM PMSF, 200 ,uM DTE. This was loaded on 
a cellulose phosphate column (10 x 2.5 cm) and 
eluted with a linear NaCl gradient (O-O.6 M). 4 ml 
fractions were collected and the protein concentra- 
tion determined by the absorbance at 280 nm; 
50~1 aliquots were assayed for phospholipase C 
activity using the neutral solvent extraction. 
A D/L mixture of Ins 1,2>P was prepared using 
10 mg D-myo-Ins 2P (dicyclohexylamine form) 
and L-myo-[14C]Ins 1P (0.25 &i) as starting 
materials. A 3 h reaction time was used, following 
a preliminary time course which indicated no ap- 
preciable increase in formation of product after 
this time [20]. The Ins 1,2>P product was purified 
on Partisil SAX-10 by the same gradient system 
described for analysis of inositol monophosphates, 
rather than the recrystallization method in [20]. 
The identity of the product was verified by descen- 
ding paper chromatography [21] of both acid- 
treated and untreated standards. Each lane was cut 
into 2 cm strips and the radioactivity determined. 
The acid-treated material co-migrated with Ins 1P 
and Ins 2P while the untreated material ran with 
similar mobility to GroPIns [21]. 
2.4. HPLC analysis 
2.2. Assay for phospholipase C 
Phosphatidyl[2-3H]inositol and unlabelled 
PtdIns were resuspended in 0.45 ml of 50 mM Tris 
maleate NaOH (pH 5.5), 1 mM CaCl2 at a final 
concentration of 3 x 10m4 M and warmed to 37°C. 
50 ,ul of the phospholipase C preparation was add- 
ed, incubated for 10 min and stopped either by a 
neutral solvent extraction, 1.8 ml chloroform/ 
methanol (1: 2, v/v), followed by 0.6 ml chlo- 
roform and 0.6 ml H20; or acidic solvent extrac- 
All HPLC analysis was carried out on a 15 x 
0.5 cm column of Partisil SAX-10 preceded by a 
5 x 0.5 cm guard column. A flow rate of 
1.3 ml/min and a 1 min fraction collection interval 
was used routinely. The sample was loaded in a 
final volume of 2 ml, made up to this volume with 
1 ml of 1 mM EDTA containing CAMP and AMP 
(0.05 mg/ml). The routine spiking of the samples 
with these adenine nucleotides, which co-eluted 
with Ins 1,2>P and Ins 1P respectively, enabled 
assessment of the elution profile by following their 
absorbance at 254 nm. The inositol phosphates 
were eluted initially for 5 min with water to 
remove any inositol. This was followed by a 
24 min linear gradient, O-300 mM ammonium 
24 
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‘formate buffered to pH 5.0 with orthophosphoric 
acid. The eluting buffer was maintained at 
300 mM ammonium formate (pH 5.0) for a fur- 
ther 6 min before returning to water over a 2 min 
period. 
3. RESULTS 
Chromatography of peak II (obtained following 
gel filtration) on cellulose phosphate (fig.11 pro- 
vided a rapid and efficient method for the resolu- 
tion of two further species of phospholipase C 
from the lymphocyte, designated PLC A and PLC 
B. Both species displayed approximately equal 
proportions of activity and each retained its elu- 
tion characteristics if re-loaded onto a fresh 
cellulose phosphate column, PLC B having 
previously been re-equilibrated with the column 
buffer. Overall, a 47-fold purification of PLC A 
and 167-fold purification for PLC B were achieved 
by this two-step purification method. These two 
species were used in the subsequent experiments to 
investigate the nature of inositol phosphates pro- 
duced following their action on PtdIns. 
The HPLC elution conditions used here resulted 
in successful resolution of GroPIns, Ins 1,2>P and 
Ins IP, in all cases a baseline separation being 
achieved. Fig.2a,b shows the production of both 
Ins 1P and Ins 1,2>P with each species of 
phospholipase C. PLC A produces predominantly 
Fig. 1. Cellulose phosphate column chromatography of 
Sephacryl S-ZOO fractionated phospholipase C. (A) 
Absorbance at 280 nm. (e) Phospholipase C activity 
assayed at pH 5.5 as described in section 2. The broken 
line represents the NaCl eluting concentration. (A) Peak 
containing PLC A, (B) peak containing PLC B. 
5 10 ‘15 20 25 30 35 
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Fig.2. Chromatography on Partisil SAX-10 of inositol 
phosphate products extracted under neutral and acidic 
conditions. HPLC profiles of (a) PLC A, neutral 
extraction; (b) PLG B, neutral extraction; (c) PLC A, 
acid extraction; (d) PLC B, acid extraction. The broken 
line indicates the ammonium formate elution gradient. 
the cyclic monophosphate while PLC B produces 
these two isomers in approximately equal 
amounts. The percentage ratios of these two 
products showed remarkably little variation be- 
tween experimental samples (table 1). When the in- 
cubation of PtdIns with the two species of phos- 
pholipase C was performed with extraction of the 
products under acidic conditions, in both cases the 
first peak was abolished and the second peak in- 
creased by an amount approximating to the loss of 
the first peak (fig.ltc,d). This confirms that the 
first peak was indeed Ins 1,2>P and the broader 
second peak resulting from acidic extraction condi- 
25 
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Table 1 
Water-soluble products released following hydrolysis of 
phosphatidylinositol catalysed by phospholipase C 
Enzyme % Ins 1,2>P % Ins 1P 
PLC A 64.9 + 1.35 34.7 + 1.24 
PLC B 51.8 * 0.55 48.1 f 0.54 
Phospholipase C assays contained 3 x 10e4 M PtdIns, in 
50 mM maleate-NaOH buffer (pH 5.5) containing 1 x 
10m3 M CaClz buffered with EDTA. The assay was 
carried out at 37°C for 10 min and stopped by the 
neutral solvent extraction. The percentage values 
expressed here are a means k SE of the results obtained 
from a total of three separate experiments, on each 
occasion using a sample of freshly prepared 
phospholipase C. The total number of samples for each 
value was 7 
each enzyme species. The two enzymes that have 
been purified from sheep seminal vesicles also syn- 
thesize different proportions of cyclic products [S], 
the mean for PLC-I being 68% Ins 1,2>P and for 
PLC-II 45% Ins 1,2>P. However, using a mass 
spectrometric technique following IgO labelling, 
these workers found a greater variation in the 
relative amounts of cyclic and non-cyclic product 
than we have found using HPLC of the products 
formed. It is the significant difference in the pro- 
portions of Ins 1,2>P and Ins 1P produced by 
these two enzyme species, resulting from the very 
small standard deviations obtained from enzymes 
prepared on different occasions, that prompts us 
to make the suggestion that this ratio is an intrinsic 
property of the individual iso-enzyme mechanism. 
The physiological significance of this finding re- 
mains to be determined. 
tions represents an isomeric mixture of Ins 1P and 
Ins 2P. 
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